Skip to main content
Equibles

DIVERSIFY WEALTH MANAGEMENT, LLC

Position in ABVX — Abivax S.A.

CIK 2030780 SANDY, UT
Back to ABVX Full portfolio

Position in ABVX

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$2,774,073
+$799,170 QoQ
Shares Held
20,817
+17.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#134
of 302 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIVERSIFY WEALTH MANAGEMENT, LLC holds $27,989,725 across 15 Biotechnology names. ABVX ranks #3 (9.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 22,168 $11,011,510
2 ASND
Ascendis Pharma A/S
 11,181 $2,982,196
3 ABVX
Abivax S.A.
This page 		20,817 $2,774,073
4 HALO
Halozyme Therapeutics, Inc.
 33,976 $2,659,301
5 LGND
Ligand Pharmaceuticals Inc
 7,956 $2,514,812
6 ARGX
Argenx SE
 2,197 $2,038,310
7 DBVT
DBV Technologies S.A.
 89,692 $1,470,948
8 REGN
Regeneron Pharmaceuticals, Inc.
 1,211 $755,106

All Filings in ABVX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,774,073 20,817
2026-03-31 $1,974,903 17,736
2025-12-31 $419,399 3,110